ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Laboratories Executive: Planning to Grow Nutrition Business in India

By Rumman Ahmed BANGALORE--Abbott Laboratories (ABT) is looking at having a fully integrated business model to grow its nutrition business in India, where it has plans to add local manufacturing as well as sales and distribution functions to its research and development capabilities, a senior executive said Monday. Abbott Monday inaugurated its first nutrition research and development center in the South Asian nation through a tie-up with a unit of Indian biotechnology company Biocon Ltd. (532523.BY). "India is a growth area for us. We have research now. To be fully integrated, we will have everything from research to manufacturing to sales (in India)," John Landgraf, executive vice president of Abbott's global nutrition business, said in an interview. Mr. Landgraf didn't elaborate on Abbott's plans for setting up local manufacturing operations, but said it is the "next phase" of the company's programs for the nutrition business in India. Abbott had last month unveiled its collaboration with Syngene International Ltd., Biocon's contract research unit, to develop nutrition products targeting those afflicted by malnutrition and diabetes in the South Asian nation. Write to Rumman Ahmed in Bangalore at rumman.ahmed@dowjones.com

Stock News for Abbott Labs (ABT)
DateTimeHeadline
04/15/201509:00:00New Blood Glucose Meter Provides People with Diabetes an Accurate...
04/14/201509:00:00Abbott and Sekisui Collaborate to Offer Coagulation Testing for...
04/14/201509:00:00Abbott and Sekisui Collaborate to Offer Coagulation Testing for...
04/13/201510:00:00Boston Athletic Association And Abbott Announce Multiple-Year...
04/13/201504:58:57Taking A Financial Mulligan With Dividend Investing
04/10/201517:01:51Current Report Filing (8-k)
04/08/201513:48:46Mylan Bids $205/Share for Generic Drug Maker Perrigo--4th Update
04/08/201512:48:19Mylan Bids $205/Share for Generic Drug Maker Perrigo--3rd Update
04/08/201512:40:10Mylan Bids $205/Share for Generic Drug Maker Perrigo--3rd Update
04/03/201503:41:38Abbott Laboratories: A Great Long-Term Investment
04/02/201517:06:41Statement of Changes in Beneficial Ownership (4)
04/02/201517:06:15Statement of Changes in Beneficial Ownership (4)
04/02/201517:06:15Statement of Changes in Beneficial Ownership (4)
04/02/201517:05:50Statement of Changes in Beneficial Ownership (4)
04/02/201517:04:32Statement of Changes in Beneficial Ownership (4)
04/02/201517:04:32Statement of Changes in Beneficial Ownership (4)
04/02/201517:04:04Statement of Changes in Beneficial Ownership (4)
04/02/201517:03:39Initial Statement of Beneficial Ownership (3)
04/02/201509:09:03Is AbbVie Inc. Stock About to Crash?
04/02/201509:00:00First-of-its-Kind Diabetes Technology Revolutionizes How Glucose...

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad